Labrosse Nicole Insider Trades

Insider Trading History

Track insider trading activity for Labrosse Nicole. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $1.6M 22,393 shares
Last Trade
Sep 22, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$174k 2,227 shares
$77.95
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $58.1k 812 shares
Last Trade
Sep 10, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$940k 12,406 shares
$75.80
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $3.17M 44,306 shares
Last Trade
Sep 10, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$940k 12,406 shares
$75.80
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $2.69M 37,546 shares
Last Trade
Sep 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.51M 20,000 shares
$75.71
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $1.44M 20,063 shares
Last Trade
Feb 23, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$386k 6,688 shares
$57.75
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $2.28M 31,900 shares
Last Trade
Feb 23, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$208k 3,601 shares
$57.75
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $2.54M 35,501 shares
Last Trade
Feb 23, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$386k 6,688 shares
$57.75
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $1.62M 22,603 shares
Last Trade
Feb 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.3M 22,603 shares
$57.44
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $2.06M 28,813 shares
Last Trade
Feb 16, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$875k 15,011 shares
$58.29
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $1.15M 15,993 shares
Last Trade
Feb 15, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$43.2k 741 shares
$58.29
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $0 0 shares
Last Trade
Feb 15, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$73.1k 1,254 shares
$58.29
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $1.2M 16,734 shares
Last Trade
Feb 15, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$73.1k 1,254 shares
$58.29
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $1.11M 15,480 shares
Last Trade
Jul 22, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$270k 5,000 shares
$53.93
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $1.4M 19,488 shares
Last Trade
Jul 22, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$272k 5,000 shares
$54.34
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $0 0 shares
Last Trade
Jul 22, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$272k 5,000 shares
$54.34
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $1.82M 25,480 shares
Last Trade
Jun 28, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$524k 10,000 shares
$52.36
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $1.11M 15,480 shares
Last Trade
Jun 28, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$520k 10,000 shares
$52.04
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $358k 5,000 shares
Last Trade
Jun 28, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$524k 10,000 shares
$52.36
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $1.07M 15,000 shares
Last Trade
Jun 27, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$516k 10,000 shares
$51.63
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, CHIEF FINANCIAL OFFICER
Holding Value $1.11M 15,480 shares
Last Trade
Jun 27, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$519k 10,000 shares
$51.93
$71.60

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up